Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
MOMA Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
BeOne Medicines
MOMA Therapeutics
Astellas Pharma Inc
Astellas Pharma Inc
Eli Lilly and Company
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Plexium, Inc.
Eilean Therapeutics
Deciphera Pharmaceuticals, LLC
Revolution Medicines, Inc.
USWM, LLC (dba US WorldMeds)
ARTBIO Inc.
Coherus Oncology, Inc.
Suzhou Abogen Biosciences Co., Ltd.
Conjupro Biotherapeutics, Inc.
Modulation Therapeutics, Inc.
Alterome Therapeutics, Inc.
IDEAYA Biosciences
ImmunityBio, Inc.
Pfizer
Eli Lilly and Company
Aptamer Sciences, Inc.
Erasca, Inc.
Novartis
Eli Lilly and Company
GlaxoSmithKline
Eli Lilly and Company
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
K36 Therapeutics, Inc.
Daiichi Sankyo
Orano Med LLC
Daiichi Sankyo
Pyxis Oncology, Inc
Conjupro Biotherapeutics, Inc.
Amgen
Shenzhen Ionova Life Sciences Co., Ltd.
Astellas Pharma Inc
BeOne Medicines
Merck Sharp & Dohme LLC
Alpha-9 Oncology USA Inc.
Boehringer Ingelheim
BeOne Medicines
Eli Lilly and Company
Jazz Pharmaceuticals
Alterome Therapeutics, Inc.